Yeonsu Jeong, Jeong Jin Park, Min-Seok Rha, Hyung-Ju Cho
{"title":"Posterior pillar hypertrophy as a novel anatomical predictor of surgical success in obstructive sleep apnea.","authors":"Yeonsu Jeong, Jeong Jin Park, Min-Seok Rha, Hyung-Ju Cho","doi":"10.21053/ceo.2025-00200","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives.: </strong>Sleep apnea surgery is effective only for selecting patients, making it crucial to identify those who will benefit. This study aimed to introduce a novel anatomical index for selecting patients with favorable surgical outcomes.</p><p><strong>Methods.: </strong>A retrospective review was conducted on patients with obstructive sleep apnea who underwent multilevel surgery by a single surgeon at a tertiary medical institution between 2012 and 2021. Anatomical parameters, endoscopic images, and pre- and postoperative polysomnography reports were analyzed. Some patients exhibited posterior pillar hypertrophy (PPH), where the palatopharyngeal muscle is thicker than normal. To assess the effects of PPH exclusively, patients were randomly selected and subjected to propensity matching.</p><p><strong>Results.: </strong>Logistic regression analysis identified tonsil grade, body mass index, and posterior pillar thickness as significant predictors of surgical success. The success rates were significantly different between the PPH(+) and normal control PPH(-) groups, with 51.9% success in the PPH(+) group compared to 40.7% in the PPH(-) group. Additionally, the PPH(+) group showed a significant increase in the apnea-hypopnea index and oxygen desaturation index postoperatively.</p><p><strong>Conclusion.: </strong>The presence of posterior pillar hypertrophy serves as an important anatomical predictor of surgical success in obstructive sleep apnea treatment. This index helps in choosing patients and planning surgeries, potentially enhancing treatment.</p><p><strong>Results.: </strong></p>","PeriodicalId":10318,"journal":{"name":"Clinical and Experimental Otorhinolaryngology","volume":" ","pages":""},"PeriodicalIF":3.4000,"publicationDate":"2025-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Experimental Otorhinolaryngology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21053/ceo.2025-00200","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives.: Sleep apnea surgery is effective only for selecting patients, making it crucial to identify those who will benefit. This study aimed to introduce a novel anatomical index for selecting patients with favorable surgical outcomes.
Methods.: A retrospective review was conducted on patients with obstructive sleep apnea who underwent multilevel surgery by a single surgeon at a tertiary medical institution between 2012 and 2021. Anatomical parameters, endoscopic images, and pre- and postoperative polysomnography reports were analyzed. Some patients exhibited posterior pillar hypertrophy (PPH), where the palatopharyngeal muscle is thicker than normal. To assess the effects of PPH exclusively, patients were randomly selected and subjected to propensity matching.
Results.: Logistic regression analysis identified tonsil grade, body mass index, and posterior pillar thickness as significant predictors of surgical success. The success rates were significantly different between the PPH(+) and normal control PPH(-) groups, with 51.9% success in the PPH(+) group compared to 40.7% in the PPH(-) group. Additionally, the PPH(+) group showed a significant increase in the apnea-hypopnea index and oxygen desaturation index postoperatively.
Conclusion.: The presence of posterior pillar hypertrophy serves as an important anatomical predictor of surgical success in obstructive sleep apnea treatment. This index helps in choosing patients and planning surgeries, potentially enhancing treatment.
期刊介绍:
Clinical and Experimental Otorhinolaryngology (Clin Exp Otorhinolaryngol, CEO) is an international peer-reviewed journal on recent developments in diagnosis and treatment of otorhinolaryngology-head and neck surgery and dedicated to the advancement of patient care in ear, nose, throat, head, and neck disorders. This journal publishes original articles relating to both clinical and basic researches, reviews, and clinical trials, encompassing the whole topics of otorhinolaryngology-head and neck surgery.
CEO was first issued in 2008 and this journal is published in English four times (the last day of February, May, August, and November) per year by the Korean Society of Otorhinolaryngology-Head and Neck Surgery. The Journal aims at publishing evidence-based, scientifically written articles from different disciplines of otorhinolaryngology field.
The readership contains clinical/basic research into current practice in otorhinolaryngology, audiology, speech pathology, head and neck oncology, plastic and reconstructive surgery. The readers are otolaryngologists, head and neck surgeons and oncologists, audiologists, and speech pathologists.